Lessons from the Belgian experience with regulatory control during the COVID-19 pandemic for the implementation of the European IVD regulation 2017/746.
Vermeersch, Pieter; Cotton, Frédéric; De Smet, Dieteret al.
Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Language :
English
Title :
Lessons from the Belgian experience with regulatory control during the COVID-19 pandemic for the implementation of the European IVD regulation 2017/746.
Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Eurosurveillance. 2020; 25. DOI: 10.2807/1560-7917.ES.2020.25.9.2000178
Sciensano. COVID-19–Wekelijks epidemiologisch bulletin van 12 juni 2020. Available from: https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200612%20-%20NL.pdf
Koninklijk Besluit/Arrêté Royal 21/07/2017 number 2017040576.
Vermeersch P, Van Aelst T, Dequeker E. The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need forclarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care. Clin Chem Lab Med. [Epub ahead of print].
FAMHP. About the FAMHP. https://www.famhp.be/en/famhp (accessed 17th June 2020)
Tré-Hardy M, Wilmet A, Beukinga I, et al. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020; Epub ahead of print. Doi: 10.1515/cclm-2020-0594
Le V, Denoël T, Leloup D, Coronavirus enquête: 7 millions pour un test controversé. Le Vif 2020; 25 [Epub ahead of print] Available from: https://www.levif.be/actualite/belgique/coronavirus-enquete-7-millions-pour-un-test-controverse/article-normal-1300775.html
Brugnera R., Kocht België onbetrouwbare coronatests? FAGG-topman komt in opspraak. Knack. 2020; 25. [Epub ahead of print] Available from https://www.knack.be/nieuws/belgie/kocht-belgie-onbetrouwbare-coronatests-fagg-topman-komt-in-opspraak/article-longread-1610423.html
Tré-Hardy M, Blairon L, Wilmet A, et al. The role of serology for COVID-19 control: population, kinetics and test performance do matter. J Infect. Epub ahead of print 2020. DOI: 10.1016/j.jinf.2020.05.019
Herroelen PH, Martens GA, De Smet D, et al. Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests. DOI: 10.1101/2020.06.09.20124719
RIVM rapportage taskforce serologie–Landelijke coördinatie testcapaciteit: status validatie ELISA en auto-analyzers: versie 2 juni 2020. Available from: https://www.rivm.nl/sites/default/files/2020-06/Status%20en%20resultaten%20validatie%20ELISA%20en%20auto-analyzers_20200602_final.pdf
Koninklijk Besluit/Arrêté Royal 31/12/2019 number 1999024072.
